¸Ê°±¶ìÍÑÑõµ¨ËáÄÆ(GCDA),GCDAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
SDS-PAGEøÆ×·¨,ZymogaphyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θµ°°×øÔÑÇȺ,pepsinogenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Snail1µ°°×,Snail1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
SLP-2µ°°×,SLP-2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
È©ÇâÒ¶Ëá¸Æ,LeucovorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
E-¸Æð¤µ°°×/²¡Àíѧ,E-cadherin/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¦Â-Á¬»·ËØ/²¡Àíѧ,¦Â-catenin/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×éÖ¯ÆðÔ´/²¡Àíѧ,histogenesis/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾¸Ø,transanalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ïã¹½¶àÌÇ×¢ÉäÒº,lentinasÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹ÜÄÚÆ¤Ï¸°ûÉú³¤Òò×Ó·´Òå¹ÑºËÜÕËá,VEGF-ASODNÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¦Â-Smac»ùÒò,¦Â-SmacÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍâÒõ²¿,CunnusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Î¶¯Âö¹à×¢»¯ÁÆ,TAIÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CD34/ÉúÎïºÏ³É,CD34/biosynthesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
賦µÀ¼äÖÊÁö-T1ϸ°û,GIST-T1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾Ð͸Æð¤¸½µ°°×,N-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
mTOR/p70S6KÐźÅͨ·,mTOR/p70S6KÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¦Î¸Çå·½,ChangweiqingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
18O±ê¼Ç,18O-labelingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÙÁö-°©,Adenoma-to-CancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
É«ËØÎ¸¾µ,ChromoendoscopyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×ÁöÒÖÖÆËØ,OSMÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×ÁöÒÖÖÆËØÊÜÌå,OSMRÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
3-(5¡ä-ôǼ׻ù-2¡ä-ß»à«)-1-ÜлùßÅßò,3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazoleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»ùÒòÄÉÃ׸´ºÏÎï,DNA-Nanoparticle(DNA-NP)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾Æ¤´©´Ì΢²¨Äý¹ÌÖÎÁÆ,PMCTÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö±³¦°©Ç°ÇгýÊõ,DixonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶þ±½ÒÒÏ©Àà/·ÖÎö,stilbenes/analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶¡ÍªÀà/·ÖÎö,butanones/analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
éÎÜÎÉ¢,HuqisanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾Æ¤¾¸Îµ¨¹ÜÖùÜÒýÁ÷,PTBDÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ëë×Ì춬ø14,Caspase14Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¦Á-L-ÑÒÔåÌÇÜÕø/ѪҺ,alpha-L-Fucosidase/analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¦Ã-¹È°±õ£×ªÒÆÃ¸/·ÖÎö,gamma-Gluyamyltransferase/analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼×Ì¥µ°°×-L3,AFP-L3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Axinµ°°×,AxinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö±³¦³åÏ´,RectaldouchingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍÙÒºËữLewis X¿¹Ô,SialylLewis-XÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÍâÐźŵ÷½Ú¼¤Ã¸1,ERK1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÙÌåÔöÉú,hyperliferationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»·ÑõºÏø-2,¦Â-Á´½ÓËØ,Cyclooxgenase-2,¦Â-cateninÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¡ÏË»ùÒòµ÷½ÚÒò×Ó,MR1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈËʳµÀ°©Ï¸°û,Ec9706Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³Éµ°°×¼Ò×å,ForminÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
E-¸ÆÕ³ËØ,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÂÃ¹ËØ,tunicamycinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ż·¢Áö,IncidentalomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ËèÐÔÖ¬·¾Áö,MyelolipomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔöÖ³ÐÔϸ°ûºË¿¹Ô,PCNAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢СÐÍ,miniatureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
MCNP³ÌÐò,MCNP codeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃÚÈéËØÁö,prolactinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈéÍ·×´/Íâ¿ÆÑ§,papillary/surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉÏÆ¤¸ÆÕ³¸½µ°°×,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
N-¼×»ùÑÇÏõ»ùëå,N-methyl-N-nitrosoureaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ËèÑùÖ¬·¾Áö,myelolipomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
p73µ°°×,p73 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾«ëß,SpermidineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ÏɼÍéÀà,taxoidsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÑÉïÖÐÆÚÒò×Ó,MidkineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºËØÁö/Õï¶Ï,Insulinoma/diagÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾µûñ¼,TranssphenoidalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ñÐÔÐØÏÙÁö,malignant thymomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°°ÄÚ,IntrasellaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙÊÖÊõ,adrenalectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»¯Ñ§Ö°©¼Á,carcinogenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ƫä,HemianopiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ͼÏñºó´¦Àí¼¼Êõ,post-processingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µÍ¼×»ù»¯,hypomethylationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
P-¸ÆÕ³µ°°×,P-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÓÒ°¼ì²é,perimetryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÔ΢Çгý,microsurgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ëÈéÌÇÄýËØ-3,galectin-3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´¹ÌåÇгý,hypophysectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ç÷»¯Òò×ÓÊÜÌå-4,CXCR4Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºÁö,insulinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Êȸõϸ°ûÁö/Õï¶Ï,Pheochromocytoma/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µÍ¶È¶ñÐÔ,low-degreeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Meninµ°°×,MeninÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Êȸõϸ°ûÁö/²¡Àíѧ,pheochromocytoma/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÞ¹¦ÄÜ,NonfunctionalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȸßѪÌÇËØÁö,GlucagonomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ËɹûÌåĸϸ°ûÁö,pineoblastomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Çå¼×,thyroidectomÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
DACH1µ°°×,DACH1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÉÏÏÙÖ×Áö/²¡Àíѧ/Õï¶Ï,Cavernous/pathology/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÈËáÁ£Ï¸°û/²¡Àíѧ,Oxyphilic/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼äôǼ×ÉöÉÏÏÙËØÀàÎïÖÊ,metanephrinesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
4-ôÇ»ùËûĪÎô·Ò,4-hydroxytamoxifenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Ö»¯ÐÍ/Õï¶Ï,Differentiated/diagÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Ö»¯ÐÍ/ÖÎÁÆ,Differentiated/therÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÆ/µâÐͬתÔËÌå,Na+/I-symportorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
À¼ÈðëÄ,lanreotideTMÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Àà¸ÎËØÃ¸-1,Heparanase-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃÚÈéËØÐÍ´¹ÌåÏÙÁö,MacroprolactinomasÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Gµ°°×żÁªÊÜÌå48,GPR48Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÈÉýÌÇËØÁö,glucagonomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´¹ÌåÏÙÁö,Pituitary adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|